Skip to main content
Top
Published in: Current Diabetes Reports 4/2011

01-08-2011

Screening for the High-risk Foot of Ulceration: Tests of Somatic and Autonomic Nerve Function

Authors: Vasiliki Argiana, Ioanna Eleftheriadou, Nicholas Tentolouris

Published in: Current Diabetes Reports | Issue 4/2011

Login to get access

Abstract

Diabetic foot ulcers affect almost 5% of the patients with diabetes and carry a huge physical, emotional, and financial burden. Almost 80% of amputations in patients with diabetes are preceded by a foot ulcer. The need for simple screening methods for prevention of foot ulcers and amputations is indisputable. Simple tests such as monofilament, tuning fork, vibration perception threshold determination, ankle reflexes, and pinprick sensation alone or in combination have been studied prospectively and can be used for identification of patients at risk. Newer tests examining sudomotor dysfunction and skin dryness have been introduced in recent years. In cross-sectional studies sudomotor dysfunction assessed by either sympathetic skin response or NEUROPAD™ (Miro Verbandstoffe GmbH, Wiehl-Drabenderhöhe, Germany) testing has been consistently associated with foot ulceration. In addition, NEUROPAD™ testing is simple, reproducible, and widely available and has a high sensitivity for the diagnosis of clinical or subclinical diabetic polyneuropathy. Prospective studies are required to establish whether sudomotor dysfunction can predict foot ulcers and if simple methods assessing sudomotor dysfunction (eg, NEUROPAD™ testing) can be included in the screening tests for the prevention of this complication.
Literature
1.
go back to reference Vileikyte L. Diabetic foot ulcers: a quality of life issue. Diabetes Metabol Res Rev. 2001;17:246–9.CrossRef Vileikyte L. Diabetic foot ulcers: a quality of life issue. Diabetes Metabol Res Rev. 2001;17:246–9.CrossRef
2.
go back to reference Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet. 2005;366:1719–24.PubMedCrossRef Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet. 2005;366:1719–24.PubMedCrossRef
3.
go back to reference Gibbons GM, Eliopoulos GM. Infection of the diabetic foot. In: Kozak GP, Campbell DR, Frykberg RG, Habershaw GM, editors. Management of diabetic foot problems. Philadelphia: Saunders; 1995. p. 121–9. Gibbons GM, Eliopoulos GM. Infection of the diabetic foot. In: Kozak GP, Campbell DR, Frykberg RG, Habershaw GM, editors. Management of diabetic foot problems. Philadelphia: Saunders; 1995. p. 121–9.
4.
go back to reference Reiber GE, Boyko EJ, Smith DG. Lower extremity foot ulcers and amputation in diabetes. In: Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH, editors. Diabetes in America. Washington: U.S.Govt. Printing Office; 1995. p. 409–28. Reiber GE, Boyko EJ, Smith DG. Lower extremity foot ulcers and amputation in diabetes. In: Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH, editors. Diabetes in America. Washington: U.S.Govt. Printing Office; 1995. p. 409–28.
5.
go back to reference Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 1999;22:382–7.PubMedCrossRef Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 1999;22:382–7.PubMedCrossRef
6.
go back to reference Siitonen OI, Niskanen LK, Laakso M, Siitonen JT, Pyorala K. Lower-extremity amputations in diabetic and nondiabetic patients: a population-based study in eastern Finland. Diabetes Care. 1993;16:16–20.PubMedCrossRef Siitonen OI, Niskanen LK, Laakso M, Siitonen JT, Pyorala K. Lower-extremity amputations in diabetic and nondiabetic patients: a population-based study in eastern Finland. Diabetes Care. 1993;16:16–20.PubMedCrossRef
7.
go back to reference Trautner C, Haastert B, Giani G, Berger M. Incidence of lower limb amputations and diabetes. Diabetes Care. 1996;19:1006–9.PubMedCrossRef Trautner C, Haastert B, Giani G, Berger M. Incidence of lower limb amputations and diabetes. Diabetes Care. 1996;19:1006–9.PubMedCrossRef
8.
go back to reference Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, et al. American Diabetes Association. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28:956–62.PubMedCrossRef Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, et al. American Diabetes Association. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28:956–62.PubMedCrossRef
9.
go back to reference Resnick HE, Carter EA, Lindsay R, Henly SJ, Ness FK, Welty TK, et al. Relation of lower-extremity amputation to all-cause and cardiovascular disease mortality in American Indians: the Strong Heart Study. Diabetes Care. 2004;27:1286–93.PubMedCrossRef Resnick HE, Carter EA, Lindsay R, Henly SJ, Ness FK, Welty TK, et al. Relation of lower-extremity amputation to all-cause and cardiovascular disease mortality in American Indians: the Strong Heart Study. Diabetes Care. 2004;27:1286–93.PubMedCrossRef
10.
go back to reference Hambleton IR, Jonnalagadda R, Davis CR, Fraser HS, Chaturvedi N, Hennis AJ. All-cause mortality after diabetes-related amputation in Barbados: a prospective case-control study. Diabetes Care. 2009;32:306–7.PubMedCrossRef Hambleton IR, Jonnalagadda R, Davis CR, Fraser HS, Chaturvedi N, Hennis AJ. All-cause mortality after diabetes-related amputation in Barbados: a prospective case-control study. Diabetes Care. 2009;32:306–7.PubMedCrossRef
11.
go back to reference Boulton AJ. Lowering the risk of neuropathy, foot ulcers and amputations. Diabet Med. 1998;15:S57–9.PubMedCrossRef Boulton AJ. Lowering the risk of neuropathy, foot ulcers and amputations. Diabet Med. 1998;15:S57–9.PubMedCrossRef
12.
go back to reference •• Boulton AJ, Armstrong DG, Albert SF, Frykberg RG, Hellman R, Kirkman MS, et al.: Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care 2008, 31:1679–85. A report of the task force of the American Diabetes Association and the American Association of Clinical Endocrinologists on risk assessment and foot examination in patients with diabetes.PubMedCrossRef •• Boulton AJ, Armstrong DG, Albert SF, Frykberg RG, Hellman R, Kirkman MS, et al.: Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care 2008, 31:1679–85. A report of the task force of the American Diabetes Association and the American Association of Clinical Endocrinologists on risk assessment and foot examination in patients with diabetes.PubMedCrossRef
13.
go back to reference Armstrong DG. The 10-g monofilament: the diagnostic divining rod for the diabetic foot. Diabetes Care. 2000;23:887.PubMedCrossRef Armstrong DG. The 10-g monofilament: the diagnostic divining rod for the diabetic foot. Diabetes Care. 2000;23:887.PubMedCrossRef
14.
go back to reference Pham H, Armstrong DG, Harvey C, Harkless LB, Giurini JM, Veves A. Screening techniques to identify the at risk patients for developing diabetic foot ulcers in a prospective multicenter trial. Diabetes Care. 2000;23:606–11.PubMedCrossRef Pham H, Armstrong DG, Harvey C, Harkless LB, Giurini JM, Veves A. Screening techniques to identify the at risk patients for developing diabetic foot ulcers in a prospective multicenter trial. Diabetes Care. 2000;23:606–11.PubMedCrossRef
15.
go back to reference Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, et al. The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med. 2002;19:377–84.PubMedCrossRef Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, et al. The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med. 2002;19:377–84.PubMedCrossRef
16.
go back to reference Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293:217–28.PubMedCrossRef Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293:217–28.PubMedCrossRef
17.
go back to reference Crawford F, McCowan C, Dimitrov BD, Woodburn J, Wylie GH, Booth E, Leese GP, Bekker HL, Kleijnen J, Fahey T: The risk of foot ulceration in people with diabetes screened in community settings: findings from a cohort study. QJM 2010, Epub ahead of print. Crawford F, McCowan C, Dimitrov BD, Woodburn J, Wylie GH, Booth E, Leese GP, Bekker HL, Kleijnen J, Fahey T: The risk of foot ulceration in people with diabetes screened in community settings: findings from a cohort study. QJM 2010, Epub ahead of print.
18.
go back to reference Tan LS. The clinical use of the 10g monofilament and its limitations: a review. Diabetes Res Clin Pract. 2010;90:1–7.PubMedCrossRef Tan LS. The clinical use of the 10g monofilament and its limitations: a review. Diabetes Res Clin Pract. 2010;90:1–7.PubMedCrossRef
19.
go back to reference Feng Y, Schlosser FJ, Sumpio BE: The Semmes Weinstein monofilament examination as a screening tool for diabetic peripheral neuropathy. J Vasc Surg 2009, 50:675–82, 682 e1. Feng Y, Schlosser FJ, Sumpio BE: The Semmes Weinstein monofilament examination as a screening tool for diabetic peripheral neuropathy. J Vasc Surg 2009, 50:675–82, 682 e1.
20.
go back to reference Feng Y, Schlosser FJ, Sumpio BE. The Semmes Weinstein monofilament examination is a significant predictor of the risk of foot ulceration and amputation in patients with diabetes mellitus. J Vasc Surg. 2010;53:220–6. e1-5.PubMedCrossRef Feng Y, Schlosser FJ, Sumpio BE. The Semmes Weinstein monofilament examination is a significant predictor of the risk of foot ulceration and amputation in patients with diabetes mellitus. J Vasc Surg. 2010;53:220–6. e1-5.PubMedCrossRef
21.
go back to reference Miranda-Palma B, Sosenko JM, Bowke JH, Mizel MS, Boulton AJM. A comparison of the monofilament with other testing modalities for foot ulcer susceptibility. Diabetes Res Clin Pract. 2005;70:8–12.PubMedCrossRef Miranda-Palma B, Sosenko JM, Bowke JH, Mizel MS, Boulton AJM. A comparison of the monofilament with other testing modalities for foot ulcer susceptibility. Diabetes Res Clin Pract. 2005;70:8–12.PubMedCrossRef
22.
go back to reference • Perkins BA, Orszag A, Ngo M, Ng E, New P, Bril V: Prediction of incident diabetic neuropathy using the monofilament examination: a 4-year prospective study. Diabetes Care 2010, 33:1549–1554. A recent prospective study showing that a scoring system of monofilament testing predicts development of neuropathy.PubMedCrossRef • Perkins BA, Orszag A, Ngo M, Ng E, New P, Bril V: Prediction of incident diabetic neuropathy using the monofilament examination: a 4-year prospective study. Diabetes Care 2010, 33:1549–1554. A recent prospective study showing that a scoring system of monofilament testing predicts development of neuropathy.PubMedCrossRef
23.
go back to reference Booth J, Young MJ. Differences in the performance of commercially available 10-g monofilaments. Diabetes Care. 2000;23:984–8.PubMedCrossRef Booth J, Young MJ. Differences in the performance of commercially available 10-g monofilaments. Diabetes Care. 2000;23:984–8.PubMedCrossRef
24.
go back to reference Van Deursen RW, Sanchez MM, Derr JA, Becker MB, Ulbrecht JS, Cavanagh PR. Vibration perception threshold testing in patients with diabetic neuropathy: ceiling effects and reliability. Diabet Med. 2001;18:469–75.PubMedCrossRef Van Deursen RW, Sanchez MM, Derr JA, Becker MB, Ulbrecht JS, Cavanagh PR. Vibration perception threshold testing in patients with diabetic neuropathy: ceiling effects and reliability. Diabet Med. 2001;18:469–75.PubMedCrossRef
25.
go back to reference Young MJ, Breddy JL, Veves A, Boulton AJ. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care. 1994;17:557–60.PubMedCrossRef Young MJ, Breddy JL, Veves A, Boulton AJ. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care. 1994;17:557–60.PubMedCrossRef
26.
go back to reference Elliott J, Tesfaye S, Chaturvedi N, Gandhi RA, Stevens LK, Emery C, et al. Large-fiber dysfunction in diabetic peripheral neuropathy is predicted by cardiovascular risk factors. Diabetes Care. 2009;32:1896–900.PubMedCrossRef Elliott J, Tesfaye S, Chaturvedi N, Gandhi RA, Stevens LK, Emery C, et al. Large-fiber dysfunction in diabetic peripheral neuropathy is predicted by cardiovascular risk factors. Diabetes Care. 2009;32:1896–900.PubMedCrossRef
27.
go back to reference Martin CL, Waberski BH, Pop-Busui R, Cleary PA, Catton S, Albers JW, et al. Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the DCCT/EDIC study. Diabetes Care. 2010;33:2635–41.PubMedCrossRef Martin CL, Waberski BH, Pop-Busui R, Cleary PA, Catton S, Albers JW, et al. Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the DCCT/EDIC study. Diabetes Care. 2010;33:2635–41.PubMedCrossRef
28.
go back to reference McGill M, Molyneaux L, Yue DK. Which diabetic patients should receive podiatry care? An objective analysis. Intern Med J. 2005;35:451–6.PubMedCrossRef McGill M, Molyneaux L, Yue DK. Which diabetic patients should receive podiatry care? An objective analysis. Intern Med J. 2005;35:451–6.PubMedCrossRef
29.
go back to reference Boulton AJ, Malik RA, Arezzo JC, Sosenko JM. Diabetic somatic neuropathies. Diabetes Care. 2004;27:1458–86.PubMedCrossRef Boulton AJ, Malik RA, Arezzo JC, Sosenko JM. Diabetic somatic neuropathies. Diabetes Care. 2004;27:1458–86.PubMedCrossRef
30.
go back to reference Veves A, Murray HJ, Young MJ, Boulton AJ. The risk of foot ulceration in diabetic patients with high foot pressure: a prospective study. Diabetologia. 1992;35:660–3.PubMedCrossRef Veves A, Murray HJ, Young MJ, Boulton AJ. The risk of foot ulceration in diabetic patients with high foot pressure: a prospective study. Diabetologia. 1992;35:660–3.PubMedCrossRef
31.
go back to reference Caselli A, Pham H, Giurini JM, Armstrong DG, Veves A. The forefoot-to-rearfoot plantar pressure ratio is increased in severe diabetic neuropathy and can predict foot ulceration. Diabetes Care. 2002;25:1066–71.PubMedCrossRef Caselli A, Pham H, Giurini JM, Armstrong DG, Veves A. The forefoot-to-rearfoot plantar pressure ratio is increased in severe diabetic neuropathy and can predict foot ulceration. Diabetes Care. 2002;25:1066–71.PubMedCrossRef
32.
go back to reference Lavery LA, Armstrong DG, Wunderlich RP, Tredwell JL, Boulton AJM. Predictive value of foot pressure assessment as part of a population-based diabetes disease management program. Diabetes Care. 2003;26:1069–73.PubMedCrossRef Lavery LA, Armstrong DG, Wunderlich RP, Tredwell JL, Boulton AJM. Predictive value of foot pressure assessment as part of a population-based diabetes disease management program. Diabetes Care. 2003;26:1069–73.PubMedCrossRef
33.
go back to reference England JD, Gronseth GS, Franklin G, Miller RG, Asbury AK, Carter GT, et al. Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology. 2005;64:199–207.PubMedCrossRef England JD, Gronseth GS, Franklin G, Miller RG, Asbury AK, Carter GT, et al. Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology. 2005;64:199–207.PubMedCrossRef
34.
go back to reference Carrington AL, Shaw JE, Van Schie CH, Abbott CA, Vileikyte L, Boulton AJ. Can motor nerve conduction velocity predict foot problems in diabetic subjects over a 6-year outcome period? Diabetes Care. 2002;25:2010–5.PubMedCrossRef Carrington AL, Shaw JE, Van Schie CH, Abbott CA, Vileikyte L, Boulton AJ. Can motor nerve conduction velocity predict foot problems in diabetic subjects over a 6-year outcome period? Diabetes Care. 2002;25:2010–5.PubMedCrossRef
35.
go back to reference Perkins BA, Grewal J, Ng E, Ngo M, Bril V. Validation of a novel point-of-care nerve conduction device for the detection of diabetic sensorimotor polyneuropathy. Diabetes Care. 2006;29:2023–7.PubMedCrossRef Perkins BA, Grewal J, Ng E, Ngo M, Bril V. Validation of a novel point-of-care nerve conduction device for the detection of diabetic sensorimotor polyneuropathy. Diabetes Care. 2006;29:2023–7.PubMedCrossRef
36.
go back to reference Vinik AI, Kong X, Megerian JT, Gozani SN. Diabetic nerve conduction abnormalities in the primary care setting. Diabetes Technol Ther. 2006;8:654–62.PubMedCrossRef Vinik AI, Kong X, Megerian JT, Gozani SN. Diabetic nerve conduction abnormalities in the primary care setting. Diabetes Technol Ther. 2006;8:654–62.PubMedCrossRef
37.
go back to reference Papanas N, Ziegler D. New diagnostic tests for diabetic distal symmetric polyneuropathy. J Diabetes Complications. 2011;25:44–51.PubMedCrossRef Papanas N, Ziegler D. New diagnostic tests for diabetic distal symmetric polyneuropathy. J Diabetes Complications. 2011;25:44–51.PubMedCrossRef
38.
go back to reference Boulton AJM. The diabetic foot: from art to science. The 18th Camillo Golgi lecture. Diabetologia. 2004;47:1343–53.PubMedCrossRef Boulton AJM. The diabetic foot: from art to science. The 18th Camillo Golgi lecture. Diabetologia. 2004;47:1343–53.PubMedCrossRef
39.
go back to reference Low PA, Benrud-Larson LM, Sletten DM, Opfer-Gehrking TL, Weigand SD, O’Brien PC, et al. Autonomic symptoms and diabetic neuropathy. Diabetes Care. 2004;27:2942–7.PubMedCrossRef Low PA, Benrud-Larson LM, Sletten DM, Opfer-Gehrking TL, Weigand SD, O’Brien PC, et al. Autonomic symptoms and diabetic neuropathy. Diabetes Care. 2004;27:2942–7.PubMedCrossRef
40.
go back to reference Low VA, Sandroni P, Fealey RD, Low PA. Detection of small-fiber neuropathy by sudomotor testing. Muscle Nerve. 2006;34:57–61.PubMedCrossRef Low VA, Sandroni P, Fealey RD, Low PA. Detection of small-fiber neuropathy by sudomotor testing. Muscle Nerve. 2006;34:57–61.PubMedCrossRef
41.
go back to reference • Tentolouris N, Marinou K, Kokotis P, Karanti A, Diakomopoulou E, Katsilambros N: Sudomotor dysfunction is associated with foot ulceration in diabetes. Diabet Med 2009, 26:302–5. This cross-sectional study showed that sudomotor dysfunction assessed by SSR is associated with foot ulceration in diabetes.PubMedCrossRef • Tentolouris N, Marinou K, Kokotis P, Karanti A, Diakomopoulou E, Katsilambros N: Sudomotor dysfunction is associated with foot ulceration in diabetes. Diabet Med 2009, 26:302–5. This cross-sectional study showed that sudomotor dysfunction assessed by SSR is associated with foot ulceration in diabetes.PubMedCrossRef
42.
go back to reference Sun PC, Lin HD, Jao SH, Chan RC, Kao MJ, Cheng CK. Thermoregulatory sudomotor dysfunction and diabetic neuropathy develop in parallel in at-risk feet. Diabet Med. 2008;25:413–8.PubMedCrossRef Sun PC, Lin HD, Jao SH, Chan RC, Kao MJ, Cheng CK. Thermoregulatory sudomotor dysfunction and diabetic neuropathy develop in parallel in at-risk feet. Diabet Med. 2008;25:413–8.PubMedCrossRef
43.
go back to reference American Diabetes Association. Standardized measures in diabetic neuropathy. Consensus statement. Diabetes Care. 1995;18:59–78. American Diabetes Association. Standardized measures in diabetic neuropathy. Consensus statement. Diabetes Care. 1995;18:59–78.
44.
go back to reference Liatis S, Marinou K, Tentolouris N, Pagoni N, Katsilambros N. Usefulness of a new indicator test for the diagnosis of peripheral and autonomic neuropathy in patients with diabetes mellitus. Diabet Med. 2007;24:1375–80.PubMedCrossRef Liatis S, Marinou K, Tentolouris N, Pagoni N, Katsilambros N. Usefulness of a new indicator test for the diagnosis of peripheral and autonomic neuropathy in patients with diabetes mellitus. Diabet Med. 2007;24:1375–80.PubMedCrossRef
45.
go back to reference Quattrini C, Jeziorska M, Tavakoli M, Begum P, Boulton AJM, Malik RA. The Neuropad test: a visual indicator test for human diabetic neuropathy. Diabetologia. 2008;51:1046–50.PubMedCrossRef Quattrini C, Jeziorska M, Tavakoli M, Begum P, Boulton AJM, Malik RA. The Neuropad test: a visual indicator test for human diabetic neuropathy. Diabetologia. 2008;51:1046–50.PubMedCrossRef
46.
go back to reference • Tentolouris N, Achtsidis V, Marinou K, Katsilambros N: Evaluation of the self-administered indicator plaster neuropad for the diagnosis of neuropathy in diabetes. Diabetes Care 2008, 31:236–7. The study showed that NEUROPAD™ testing can be safely performed by the patients at home with comparable results with health care providers.PubMedCrossRef • Tentolouris N, Achtsidis V, Marinou K, Katsilambros N: Evaluation of the self-administered indicator plaster neuropad for the diagnosis of neuropathy in diabetes. Diabetes Care 2008, 31:236–7. The study showed that NEUROPADtesting can be safely performed by the patients at home with comparable results with health care providers.PubMedCrossRef
47.
go back to reference Spallone V, Morganti R, Siampli M, Fedele T, D’Amato C, Cacciotti L, et al. Neuropad as a diagnostic tool for diabetic autonomic and sensorimotor neuropathy. Diabet Med. 2009;26:686–92.PubMedCrossRef Spallone V, Morganti R, Siampli M, Fedele T, D’Amato C, Cacciotti L, et al. Neuropad as a diagnostic tool for diabetic autonomic and sensorimotor neuropathy. Diabet Med. 2009;26:686–92.PubMedCrossRef
48.
go back to reference Kamenov ZA, Petrova JJ, Christov VG. Diagnosis of diabetic neuropathy using simple somatic and a new autonomic (neuropad) tests in the clinical practice. Exp Clin Endocrinol Diabetes. 2010;118:226–33.PubMedCrossRef Kamenov ZA, Petrova JJ, Christov VG. Diagnosis of diabetic neuropathy using simple somatic and a new autonomic (neuropad) tests in the clinical practice. Exp Clin Endocrinol Diabetes. 2010;118:226–33.PubMedCrossRef
49.
go back to reference Papanas N, Giassakis G, Papatheodorou K, Papazoglou D, Monastiriotis C, Christakidis D, et al. Sensitivity and specificity of a new indicator test (Neuropad) for the diagnosis of peripheral neuropathy in type 2 diabetes patients: a comparison with clinical examination and nerve conduction study. J Diabetes Complications. 2007;21:353–8.PubMedCrossRef Papanas N, Giassakis G, Papatheodorou K, Papazoglou D, Monastiriotis C, Christakidis D, et al. Sensitivity and specificity of a new indicator test (Neuropad) for the diagnosis of peripheral neuropathy in type 2 diabetes patients: a comparison with clinical examination and nerve conduction study. J Diabetes Complications. 2007;21:353–8.PubMedCrossRef
50.
go back to reference Papanas N, Papatheodorou K, Papazoglou D, Monastiriotis C, Christakidis D, Maltezos E. A comparison of the new indicator test for sudomotor function (Neuropad) with the vibration perception threshold and the clinical examination in the diagnosis of peripheral neuropathy in subjects with type 2 diabetes. Exp Clin Endocrinol Diabetes. 2008;116:135–8.PubMedCrossRef Papanas N, Papatheodorou K, Papazoglou D, Monastiriotis C, Christakidis D, Maltezos E. A comparison of the new indicator test for sudomotor function (Neuropad) with the vibration perception threshold and the clinical examination in the diagnosis of peripheral neuropathy in subjects with type 2 diabetes. Exp Clin Endocrinol Diabetes. 2008;116:135–8.PubMedCrossRef
51.
go back to reference • Papanas N, Papatheodorou K, Papazoglou D, Kotsiou S, Maltezos E: A prospective study on the use of the Indicator Test Neuropad® for the Early Diagnosis of Peripheral Neuropathy in type 2 Diabetes. Exp Clin Endocrinol Diabetes 2010, 119:122–125. This study demonstrated that an abnormal NEUROPAD™ testing at baseline was associated with development of clinical neuropathy over a 5-year period.PubMedCrossRef • Papanas N, Papatheodorou K, Papazoglou D, Kotsiou S, Maltezos E: A prospective study on the use of the Indicator Test Neuropad® for the Early Diagnosis of Peripheral Neuropathy in type 2 Diabetes. Exp Clin Endocrinol Diabetes 2010, 119:122–125. This study demonstrated that an abnormal NEUROPADtesting at baseline was associated with development of clinical neuropathy over a 5-year period.PubMedCrossRef
52.
go back to reference •• Tentolouris N, Voulgari C, Liatis S, Kokkinos A, Eleftheriadou I, Makrilakis K, Marinou K, Katsilambros N: Moisture status of the skin of the feet assessed by the visual test neuropad correlates with foot ulceration in diabetes. Diabetes Care 2010, 33:1112–4. This cross-sectional study showed that an abnormal NEUROPAD™ response is associated with foot ulceration in diabetes and the results obtained by NEUROPAD™ testing are as informative as those obtained by other established tests used for the prediction of foot ulcers.PubMedCrossRef •• Tentolouris N, Voulgari C, Liatis S, Kokkinos A, Eleftheriadou I, Makrilakis K, Marinou K, Katsilambros N: Moisture status of the skin of the feet assessed by the visual test neuropad correlates with foot ulceration in diabetes. Diabetes Care 2010, 33:1112–4. This cross-sectional study showed that an abnormal NEUROPADresponse is associated with foot ulceration in diabetes and the results obtained by NEUROPADtesting are as informative as those obtained by other established tests used for the prediction of foot ulcers.PubMedCrossRef
53.
go back to reference American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2010;33(Suppl1):S11–61.CrossRef American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2010;33(Suppl1):S11–61.CrossRef
Metadata
Title
Screening for the High-risk Foot of Ulceration: Tests of Somatic and Autonomic Nerve Function
Authors
Vasiliki Argiana
Ioanna Eleftheriadou
Nicholas Tentolouris
Publication date
01-08-2011
Publisher
Current Science Inc.
Published in
Current Diabetes Reports / Issue 4/2011
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-011-0192-0

Other articles of this Issue 4/2011

Current Diabetes Reports 4/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.